Lupin launches generic contraceptive drug Merzee capsules in US
Slayback had earlier launched this product in the US in February 2021
 "Lupin launches generic contraceptive drug Merzee capsules in US")
Drug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market.
The Mumbai-based drug maker has launched the product in the US market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC, Lupin Ltd said in a statement.
Slayback had earlier launched this product in the US in February 2021.
Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg is a generic equivalent of Allergan Pharmaceuticals' Taytulla capsules.
As per IQVIA MAT February 2022 data, Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules, 1 mg/20 mcg had estimated annual sales of USD 90 million in the US.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)